• This record comes from PubMed

Positive and Negative Signals in Mast Cell Activation

. 2017 Sep ; 38 (9) : 657-667. [epub] 20170220

Language English Country Great Britain, England Media print-electronic

Document type Journal Article, Review, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.

Links

PubMed 28254170
DOI 10.1016/j.it.2017.01.008
PII: S1471-4906(17)30022-4
Knihovny.cz E-resources

Mast cells are powerful immune modulators of the tissue microenvironment. Within seconds of activation, these cells release a variety of preformed biologically active products, followed by a wave of mediator synthesis and secretion. Increasing evidence suggests that an intricate network of inhibitory and activating receptors, specific signaling pathways, and adaptor proteins governs mast cell responsiveness to stimuli. Here, we discuss the biological and clinical relevance of negative and positive signaling modalities that control mast cell activation, with an emphasis on novel FcεRI regulators, immunoglobulin E (IgE)-independent pathways [e.g., Mas-related G protein-coupled receptor X2 (MRGPRX2)], tetraspanins, and the CD300 family of inhibitory and activating receptors.

References provided by Crossref.org

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...